Vilnius startup Biomatter Designs claims to pioneer the technologies for generative protein design. In a recent development, the company has raised nearly half a million euros from a slew of investors. The company will be able to generate novel enzymes and protein therapeutics that would otherwise be tedious to obtain by classical experimental and computational approaches.
Investment to develop product pipeline
Well, Biomatter Designs just announced that it raised €500k led by Practica Capital along with 70V and angel investors. This fund will be used to develop the company’s protein design technology and product pipeline further.